You searched for Antibody candidate - Page 31 of 69

dragan grabulovski interview covagen acquisition

Interview 30 Oct 2017

Meet the Covagen Co-Founder that Closed Europe’s Biggest Acquisition in 2014

…So what was the technology that Covagen developed that J&J took such an interest in? We started with the development of antibody alternatives, with Fynomers — small proteins of about…

October 30, 2017 - 9 minutesmins - By Evelyn Warner

News and Trends 15 Jan 2018

British Biotech’s Technology is Taken by Pharma to Fight Alzheimer’s

…candidates that originate from F-star’s development pipeline. Each drug has been developed for a specific genetically validated target and uses Denali’s Antibody Transport Vehicle (ATV) to help therapeutics across the…

January 15, 2018 - 3 minutesmins - By Alex Dale

News and Trends 2 Apr 2020

Swiss and German Team to Develop Inhaled mRNA Coronavirus Treatment

The Swiss antibody specialist Neurimmune and the German RNA biotech Ethris are collaborating to develop inhaled messenger RNA (mRNA) antibodies that can treat the catastrophic respiratory effects of coronavirus disease,…

April 2, 2020 - 3 minutesmins - By Anita Chakraverty

tusk therapeutics cancer CD38 immunotherapy 1

News and Trends 14 Nov 2017

British Biotech Gets a £2.5M Grant to Boost Cancer Immunotherapy

…the power’ of the immune system. One of its candidates is an antibody that targets the CD38 immune checkpoint, which is a marker of cell activation that is expressed by…

November 14, 2017 - 2 minutesmins - By Alex Dale

biologics 2015 blockbusters best selling drugs

News and Trends 30 Aug 2016

Top 10 Best-selling Biologicals of 2015

…price, managed to beat it. Humira is the tradename of adalimumab, an antibody that binds to TNFα and thus reduces inflammation. It’s prescribed for rheumatoid arthritis, psoriasis, Crohn’s and other…

August 30, 2016 - 6 minutesmins - By Denise Neves Gameiro

amgen leukemia blincyto antibody bispecific

News and Trends 1 Dec 2015

How a Breakthrough Leukemia Drug is Shaping the Future of Bispecific T-Cell Therapies

…trigger the cancerous B-cell to die by apoptosis. A. Bite antibody constructs are generated by genetically linking minimal binding domains of mAbs onto a single polypeptide chain. B. Antibody constructs…

December 1, 2015 - 3 minutesmins - By Eva Cosson

multiple sclerosis by decade3d anatomy online FI

News and Trends 15 Sep 2016

Roche’s New Antibody is besting the best MS Drug

Roche is poised to blow away the competition for the new multiple sclerosis drug with its leading candidate, Ocrevus (ocrelizumab). Phase III data shows it outperforming Merck’s Rebif, the standard…

September 15, 2016 - 2 minutesmins - By Evelyn Warner

News and Trends 20 Jul 2018

Belgian Biotech Completes First Trial with New Drug for Diabetic Macular Edema

…the safety and tolerability of a new kind of antibody treatment for diabetic macular edema. The trial focused on injecting the THR-317 antibody, which is directed against the human placental…

July 20, 2018 - 2 minutesmins - By External Contributor

morphosys genmab janssen cancer immunotherapy

News and Trends 28 Jan 2019

Update: US District Court Rules Against MorphoSys’ Cancer Immunotherapy Patents

…to CD38 for the treatment of cancer, including multiple myeloma. MOR202 induces antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP) mediated killing of multiple myeloma cells. (Source: MorphoSys) With…

January 28, 2019 - 3 minutesmins - By Dani Bancroft

roche fda pd l1 checkpoint inhibitor atezolizumab

News and Trends 19 May 2016

FDA approves First ever antibody to target Cancer PD-L1

…Approval Program, and the positive decision was made after data from a Phase II trial (IMVigor 210). The candidate has shown to cause a tumor response in 26% (80 out…

May 19, 2016 - 2 minutesmins - By Denise Neves Gameiro

argenx llama inspired antibodies cover cancer immunotherapy

News and Trends 5 Dec 2018

Llama-Inspired Antibodies Succeed in Clinical Trials and Financial Deal

Autoimmune disease and acute myeloid leukemia may have a llama-inspired antibody treatment one day. The Dutch company argenx’s antibodies have shown positive results in clinical trials, and have attracted Janssen…

December 5, 2018 - 3 minutesmins - By Jonathan Smith

News and Trends 12 Jan 2017

An Antibody to reduce Hospitalizations of Children starts Phase IIb trials

…JP Morgan this year, develops nanobodies derived from llamas. The Belgian company announced yesterday that its candidate ALX-0171 has entered testing in Phase IIb as a treatment for respiratory syncytial…

January 12, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Meet the Covagen Co-Founder that Closed Europe’s Biggest Acquisition in 2014

British Biotech’s Technology is Taken by Pharma to Fight Alzheimer’s

Swiss and German Team to Develop Inhaled mRNA Coronavirus Treatment

British Biotech Gets a £2.5M Grant to Boost Cancer Immunotherapy

Top 10 Best-selling Biologicals of 2015

How a Breakthrough Leukemia Drug is Shaping the Future of Bispecific T-Cell Therapies

Roche’s New Antibody is besting the best MS Drug

Belgian Biotech Completes First Trial with New Drug for Diabetic Macular Edema

Update: US District Court Rules Against MorphoSys’ Cancer Immunotherapy Patents

FDA approves First ever antibody to target Cancer PD-L1

Llama-Inspired Antibodies Succeed in Clinical Trials and Financial Deal

An Antibody to reduce Hospitalizations of Children starts Phase IIb trials

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!